How Much Does Ozempic Cost Without Insurance in 2026?

Ozempic's official list price in 2026 is $935.77 per month—for any dose, because it's sold per pen, and a monthly supply is 4 pens. That number gets quoted everywhere. It's also largely irrelevant to what you'll actually pay.

The real answer to "how much does Ozempic cost without insurance" depends entirely on your situation: your income, whether you have any insurance at all (even if it doesn't cover Ozempic), and whether you have Type 2 diabetes vs. using it for weight loss. Let's go through each scenario clearly.

First: Why "Without Insurance" Is the Wrong Frame

The phrase "without insurance" actually splits into two very different groups:

• Uninsured: You have no health insurance at all. This opens up manufacturer patient assistance programs.
• Insured but not covered: You have insurance, but your plan doesn't cover Ozempic (or covers Ozempic for diabetes but not for weight loss). This is far more common.

The programs available to you differ dramatically based on which category you're in. Getting this wrong means leaving thousands of dollars on the table.

The Novo Nordisk Savings Card: $25/Month (With Catches)

Novo Nordisk offers an Ozempic Savings Card that caps your monthly cost at $25 per fill—for up to 24 months. On the surface, this sounds incredible. Here's the full picture:

• You must have commercial insurance. The savings card requires that your insurance is billed, even if it pays nothing. "Commercial" means employer-sponsored plans, ACA marketplace plans, or individual plans. Medicare and Medicaid are explicitly excluded.
• Income limits apply. Household income must be below a threshold (Novo Nordisk adjusts this periodically; check their site for current limits, but it's generally $150,000 or less for a family of four).
• Your insurance must not be paying more than the savings card covers. If your insurance already covers Ozempic and your copay is less than $25, you won't need the card.
• It does not work with Medicare. Federal law prohibits manufacturer coupons from being applied to Medicare prescriptions. Full stop.

The practical result: if you have commercial insurance that doesn't cover Ozempic (or covers it with a high copay), and your income is under the limit, you can get Ozempic for $25/month. That's a genuinely good deal—about $300/year for a $11,000/year drug.

NovoCare Patient Assistance: $99/Month for the Uninsured

If you're completely uninsured, Novo Nordisk's NovoCare Patient Assistance Program is your best option for brand-name Ozempic. The cost is $99 per month for income-qualified patients.

The income threshold is more restrictive than the savings card. As of 2026, individual income must be under roughly $58,000/year (400% of the federal poverty level), and family income thresholds scale accordingly. You'll need to provide proof of income and complete an application—it's not instant, expect 2–4 weeks for approval.

If you're uninsured and above the income limit? Your options narrow considerably, and this is where telehealth subscriptions become relevant.

GoodRx: Don't Get Your Hopes Up

GoodRx works by negotiating pharmacy benefit manager rates and sharing the discount with you. For generic medications, this can be transformative—you can get metformin for $4. For brand-name GLP-1s, the math is brutal.

GoodRx typically brings Ozempic to $850–$900 per month. That's a discount of roughly $35–$85 off list price. On a $935 drug, this is a rounding error. If you're considering GoodRx as your primary cost strategy for Ozempic, stop—it's not a meaningful solution here.

GoodRx is worth checking at the pharmacy as a last resort, but don't build your plan around it.

Telehealth Subscriptions: The Real Alternative

The most significant development in GLP-1 access over the past two years has been telehealth platforms offering compounded semaglutide subscriptions. Note: the legal landscape around compounded semaglutide shifted in 2025 (more on that in our compounded semaglutide guide), so check current availability.

Hims & Hers

Hims has offered compounded semaglutide at approximately $199/month at the starting dose, with higher doses priced higher. They pivoted their model after FDA shortage designations changed, so confirm current pricing and availability before signing up. The appeal: no prior auth, no insurance needed, delivered to your door.

Henry Meds

Henry Meds operates as a subscription telehealth service with compounded semaglutide at roughly $297/month, bundling medical visits, prescription management, and the medication together. Their model emphasizes ongoing clinical support alongside the medication.

Ro, Found, and Others

Multiple other platforms exist in this space. Pricing varies from $150–$400/month depending on dose and service level. The key questions to ask any of these platforms: Is the semaglutide compounded by a 503B outsourcing facility (higher quality standards) or a 503A pharmacy? Do they provide a Certificate of Analysis for each batch?

The Critical Insurance Distinction: Ozempic vs. Wegovy

Here's something that trips up a lot of people. Ozempic and Wegovy both contain semaglutide—the exact same active ingredient. But they have different FDA indications:

• Ozempic: FDA-approved for Type 2 diabetes (and cardiovascular risk reduction in T2D patients)
• Wegovy: FDA-approved for chronic weight management (obesity/overweight with comorbidities)

Insurance plans that cover Ozempic generally cover it only for Type 2 diabetes. If you're trying to use it for weight loss and you don't have T2D, insurers will deny coverage for Ozempic—even though the drug is identical to Wegovy. And Wegovy coverage? That's its own separate battle (many plans still exclude it).

If your doctor writes you an Ozempic prescription for weight loss without a T2D diagnosis, and your insurance covers Ozempic for T2D, your claim will likely get denied. This isn't a technicality—it's intentional benefit design.

Decision Tree: What You'll Actually Pay

What People Actually Pay: A Reality Check

Based on the breakdown above, here's what Ozempic actually costs in practice for different groups in 2026:

One More Thing: The Dose Matters

Ozempic comes in 0.5mg, 1mg, and 2mg weekly injection pens. You start low (0.25mg for the first month, then 0.5mg) and titrate up over time. The cost is the same regardless of dose—Novo Nordisk prices the pen, not the dose. So the $935 list price applies whether you're on 0.5mg or 2mg.

This is different from some compounded options, where you pay per milligram. Something to factor in as your dose increases.

The Bottom Line

If you have commercial insurance—even insurance that doesn't cover Ozempic—and you meet income requirements, the Novo Nordisk Savings Card is your first call. $25/month for brand-name Ozempic is genuinely accessible.

If you're uninsured and income-qualified, NovoCare at $99/month is your best option for actual Ozempic.

If neither of those apply, telehealth subscriptions offering compounded semaglutide at $150–$400/month are the realistic alternative—just understand what you're getting (compounded, not brand-name) and vet the pharmacy carefully.

Nobody should be paying $935/month for Ozempic. Use the tools available.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical or financial advice. Drug pricing changes frequently—verify current prices with Novo Nordisk, your pharmacy, and your insurance plan. Consult a licensed healthcare provider before starting any medication.